Effects of Drospirenone-containing or -Not Containing Combined Oral Contraceptives on General and Sexual Well-being (COSME)

Bayer

Status: Completed

Conditions: Contraception

Treatments: Drug: EE30-DRSP (Yasmin, BAY86-5131); Drug: Other combined oral contraceptives

Study type: Observational

Funder types: Industry

Identifiers

NCT00988910

14182

YA0711IT (Other Identifier)

Details and patient eligibility

About

The purpose of this study is to evaluate the symptoms and satisfaction for women taking drospirenone (DRSP)-containing combined oral contraceptives in comparison with women taking other kind of combined oral contraceptives.

Enrollment: 632 patients

Sex: Female

Ages: 18 to 45 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• According to the label of the prescribed Combined Oral Contraceptive (COC)
• first Combined Oral Contraceptive use or previous Combined Oral Contraceptive use
• intention to use current COC for 1 year at least

Exclusion criteria

• Contraindications listed in the label of the prescribed Combined Oral Contraceptive (COC)

Trial design

632 participants in 2 patient groups

Group 1

Treatment:

Drug: EE30-DRSP (Yasmin, BAY86-5131)

Group 2

Treatment:

Drug: Other combined oral contraceptives